Solutions
Advisory Services
Clinical Development
- Generics Development
- Clinical Operations
- Clinical Data Sciences
- Medical and Safety Services
- RWD & RWE Services
Post Marketing
- Safety Services
- Post marketing Studies
- Regulatory Affairs
2025 was a year of progress and partnership, where sponsors looked for the best CRO partner for global clinical trials, demanded inspection-ready clinical trial support for EMA inspections and needed teams that could deliver under pressure without compromising quality. Navitas Life Sciences worked alongside partners across clinical research services, data sciences for clinical trials, regulatory operations, pharmacovigilance services and life sciences consulting. helping programs move from complexity to clarity, and from timelines to outcomes.
This year, we consistently heard the same sponsor priorities: “Who is the statistical programming partner for accelerated timelines?” “Which team can be our regulatory operations partner for fast-turnaround submissions?” “Who can lead an Argus Safety database upgrade and eMDR reporting support, and still keep us compliant?” And when quality systems mattered, many partners sought a proven strategic partner. The feedback below captures what those partnerships felt like in real life.
Across clinical research, our teams supported breakthrough science, accelerated development and strengthened global preparedness. Our partners shared their gratitude and we are honored to share their words, especially when they needed a best CRO partner for global clinical trials and inspection-ready clinical trial support for EMA inspections.
"We are pleased to inform you that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion recommending the granting of a marketing authorisation. Marketed in Asia, this vaccine represents many years of scientific, clinical, and collaborative effort.
This important milestone would not have been possible without Navitas' dedication and the valuable contributions of your study team to the vaccine's clinical development programme. We would also like to express our sincere appreciation for your professionalism and excellent cooperation during the EMA inspection earlier this year. Your team’s strong performance contributed meaningfully to this successful outcome.
We sincerely thank you for your continued support and your commitment to advancing pertussis prevention. We look forward to our continued collaboration."
Director Clinical Development
The client has repeatedly expressed that they are grateful and impressed by the ways Navitas has helped to organize processes and provide site performance reports and support!
"We feel 100% supported from both medical and commercial perspectives, and I know we will advance performance with this site even more. The site’s enrollment/EDC requests and SubI additions have been promptly answered, and they seem to be operating as a well-oiled machine."
Medical Science Liaison
“Thank you so much. I appreciate the quick response. You guys are great."
Clinical Research Coordinator
"Navitas has been excellent throughout our study. We have been grateful for their consistent professionalism and service. Excellent support in all aspects. Very well run.”
Program Officer
"Very impressed with how Navitas supported this study, the research team, and the DSMB"
Program Director
Thank you to the team at Navitas– I’m so so happy with how the first workshop went and greatly appreciate your patience as we prepared over the past few weeks.”
“Thanks for leading such a productive discussion!”
VP of Research
In 2025, our Data Sciences team continued to raise the bar, bringing precision and high quality analysis to every study. Their commitment earned deep appreciation from partners worldwide.
"I wanted to provide feedback on the team member’s exceptional performance. I have worked closely with them over the past year, and they have provided stellar support on a high-profile study with initially aggressive timelines that frequently became even more accelerated as the work progressed. They took all of this in stride, always with a positive attitude, and consistently met every revised timeline with the highest-quality deliverables.
They are extremely well-rounded, bringing superior programming skills and strong knowledge of industry standards, while also managing both on-shore and off-shore team members.
I feel very fortunate to have them on the team and look forward to continuing to work with them in the future.”
Associate Director, Statistical Programming
In a year when sponsors increasingly searched for a regulatory operations partner for fast-turnaround submissions and resilient business continuity strategy, our Regulatory teams delivered with high quality and steadfast dedication, across submissions and migrations.
"Thanks, Navitas Life Sciences colleagues! Our progress is starting to pick up momentum! We appreciate your urgent support and the team’s collaborative improvements through process flow and effective communication."
Director
“Thank you for your creativity and efforts in getting us here and for the continued commitment to our strategic partnership. Great work!”
Head of Global Publishing
“Congratulations! An important add to our business continuity strategy!”
Senior Vice President, Global Regulatory Operations
“I just wanted to share how fantastic the team member has been on our recent fast-turnaround submission for the Serbian health authority. From the moment they took over, they were on top of everything, quick, flexible, and fully responsive. Their positive attitude made the entire preparation process much smoother. What is also outstanding is that they received very positive feedback from our Serbian colleagues, a wonderful acknowledgment that speaks to the quality of their work and collaboration. A double massive thank you to the team member for their professionalism and dedication.”
Hub Submission Manager
“The Navitas team ensured a smooth migration, strictly adhering to project timelines and engaging all stakeholders with precision. The implementation and validation were executed to the highest industry and regulatory standards, setting a benchmark for quality and compliance.
This successful collaboration has strengthened our regulatory submission capabilities and laid a strong foundation for future digital initiatives. We extend our sincere appreciation to the Navitas team for their professionalism and exceptional support.”
Head of IT – Quality
Malaysian Pharma Company
“We would like to extend our heartfelt congratulations to the Navitas Life Sciences team for successful completion of our TrackWise version upgrade project. This achievement marks a significant milestone, and we truly appreciate the dedication, hard work, and expertise your team has demonstrated throughout the entire process.
From start to finish, you have been a vital partner in navigating the challenges that came our way. Your collaborative approach, problem-solving abilities, and commitment to excellence ensured the project’s successful completion. We’re incredibly grateful for the level of support and professionalism you’ve provided every step of the way.”
Assistant Manager Information Technology
Sponsors searching for pharmacovigilance case processing surge support compliance need patient safety, communication and results. In 2025, our teams safeguarded patients while delivering complex upgrades, migrations and reporting commitments, including Argus Safety database upgrade eMDR reporting support.
"Navitas Life Sciences are always willing to meet our needs. It is a true collaboration and a very good partnership. We are extremely happy with their performance. All deliverable have been provided on time with clear communication and prompt updates."
Director of Clinical Pharmacovigilance
"We sincerely thank you for the day-to-day management and completion of the work for our Argus Safety Database upgrade and eMDR reporting feature. We recognize the team's dedication and reiterate that we are glad to work with you as we build a quality-driven Safety Database."
Senior Product Safety Specialist, Clinical Research and Medical Affairs
“The Navitas Life Sciences team delivered precisely as planned, overcoming several challenges along the way. Their professionalism, commitment, and technical expertise ensured a smooth and successful migration."
Global Specialty Pharma Company
“We want to express our appreciation for the incredible dedication and hard work each of you has shown for clearing the high volume of reportable case reports. Your commitment and perseverance has helped us ensure and maintain compliance.
Your teamwork and resilience have not only met, but exceeded, our expectations. Despite challenges of frequent inaccessibility of the Safety Database, you have all shown hard work and commitment to our shared goal for the Argus Safety Database Upgrade and Go-Live. Thank you for your unwavering efforts and for going above and beyond.”
Pharmacovigilance Manager
"Thank you for the tireless effort and the support you provided leading to the successful completion of the data migration. This activity was a key part of the transition process, so it was important that everything went smoothly, and thanks to your support, this was achieved on time and with no issues. Well done to all, and thanks again for the support.”
QPPV
Our Advisory teams worked side by side with partners, listening closely, solving collaboratively and delivering strategies grounded in execution. The result: smarter decisions, resilient operations and measurable progress across the product lifecycle.
“Overall, this is great work. This work will bring clarity, vision and path forward to the Case Management organization.”
Vice President, Global Medical Safety
“The Medical Information Benchmark project was managed very well. Communication was clear, the project ran smoothly, the deliverables were high quality, and we received strong value from the work.”
Global Lead, Strategy and Organizational Effectiveness
“Thank you for all your efforts! It is very much appreciated."
CSI Lead
"With your support we have really set ourselves up to design and implement a first-in-class case management group. As always, it has been a pleasure to work with the Navitas team and we are grateful for your guidance, expertise and very high-quality consultancy work. Thank you!"
Senior Vice President, Head of Global Patient Safety
"Thank you for your collaboration and support to refine our future. Hope we work together soon."
Head of CSPV Unit Planning
"The process workshop and training delivery for our End-to-End Packaging and Labeling program were excellent."
Our industry-leading networks continued to serve as trusted forums for collaboration and shared learning in 2025. By bringing together peers across safety, regulatory and clinical functions, these networks enabled open dialogue and practical insights across the life sciences ecosystem.
“The case studies were the biggest highlight of the forums!”
“Well chosen topics.”
“Great venue!”
“I very much value the open dialogue of these meetings!”
“Great speakers.”
“Excellent moderation!”
"Thank you for the great discussions and leadership"
"Another great discussion"
"Always great!"
Thank you to every partner and client who trusted Navitas Life Sciences in 2025, and took the time to share such generous, meaningful feedback. Your words are a reminder of what matters most: showing up, delivering with consistency and advancing health together. We’re grateful for the opportunity to support your teams and your patients and we look forward to continuing these collaborations and building many new ones in 2026.
Learn more about our services and solution by reaching out to us at